Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins.
Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.
Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
Up to 90% verified emails and mobile numbers, refreshed weekly.
Codexis, Inc. operates in the Biotechnology Research industry and is headquartered in United States.
Codexis, Inc. has approximately 51-200 employees employees.
Codexis, Inc. is based in Redwood City, CA, United States.
Yes. Codexis, Inc. is a publicly traded company.
You can reach Codexis, Inc.’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.
Our team will be in touch soon. If you have any questions, please email us at info@scalelist.com
Just a few more details..
Our team will be in touch soon. If you have any questions, please email us at arnaud@scalelist.com